SCHEMBL25938341

SCHEMBL25938341

FC(F)(F)c1cc(OCCBr)cc2cn(C3CCC3)nc12

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 7/20 0.41
TLR7 Q9NYK1 1/20 0.33
DGAT1 O75907 1/20 0.31
MPO P05164 1/20 0.31
MAP3K12 Q12852 1/20 0.30
IRAK4 Q9NWZ3 2/20 0.30
IRAK1 P51617 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26024428 0.84 TLR8 (0.36) TLR8
SCHEMBL25313492 0.84 TLR8 (0.36) TLR8
SCHEMBL26022451 0.73 TLR8 (0.34) TLR8MAP3K12
SCHEMBL25904920 0.72 PDK2 (0.34) TLR8
SCHEMBL31436566 0.64
SCHEMBL31067863 0.64 HPGD (0.33)
SCHEMBL25923360 0.64 TLR8 (0.38) TLR8TLR7
SCHEMBL25216639 0.64 HPGD (0.33)
SCHEMBL25317472 0.64 TLR8 (0.42) TLR8TLR7
SCHEMBL31436563 0.63 AR (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed